Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Jun 10 2022
Business
Jun 10 2022
3 min read

Press Release Jun 10 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 10-Jun-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg

View Attachment